Does a CRO need to be certified or accredited by a regulatory body?

Generally, CROs do not require specific certification or accreditation by regulatory bodies like the FDA or EMA. However, they must operate under the applicable good clinical practice (GCP) guidelines, such as ICH E6, and the sponsor is responsible for ensuring this compliance.

How does the EU MDR impact the selection of a CRO?

The EU MDR places a heightened emphasis on clinical evidence, requiring robust clinical investigations and post-market clinical follow-up. This necessitates selecting CROs with strong expertise in EU MDR-compliant clinical strategy, study design, and regulatory submissions, particularly for high-risk devices.

All terms

Industry BodiesClinical Evidence Strategic LandscapeCRO

Contract Research Organization

Service organization providing clinical trial management and supporting services to sponsors.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

Definition

A Contract Research Organization (CRO) delivers protocol design, site management, monitoring, biostatistics, regulatory submissions, safety reporting, and data management on behalf of device, IVD, biotech, and pharma sponsors. MedTech-focused CROs differ from drug CROs in their handling of device-specific endpoints, IRB/EC strategy for IDE/CIP studies, and reimbursement-grade evidence design.

What the regulation says

Regulators recognize CROs as essential partners in clinical research. For example, FDA regulations in 21 CFR Part 312 (for drugs) and 21 CFR Part 812 (for devices) outline the responsibilities of sponsors and investigators, which often extend to CROs when these organizations perform study-related duties. The EU MDR (Regulation (EU) 2017/745) also implicitly covers CRO activities by imposing stringent clinical evidence requirements on device manufacturers, who may delegate tasks to CROs.

What this means in practice

Sponsors choose CROs based on therapeutic-area expertise, geographic site footprint, and budget - and increasingly on familiarity with EU MDR/IVDR clinical evidence expectations.

Examples

A MedTech startup developing an AI-powered diagnostic delegates its pivotal clinical trial execution, including site selection, data management, and biostatistics, to a specialized CRO to meet FDA 510(k) submission requirements.
A large medical device manufacturer contracts with a CRO to manage its post-market clinical follow-up (PMCF) studies across multiple European countries to satisfy EU MDR Annex XIV Part B requirements.
An in vitro diagnostic (IVD) company partners with a CRO to conduct a performance study for a new immunoassay, ensuring adherence to ISO 20916:2019 (In vitro diagnostic medical devices - Clinical performance studies using specimens from human subjects - Good study practice) and other relevant IVDR requirements.

Common pitfalls

•Failing to establish clear lines of responsibility and communication between the sponsor and the CRO can lead to regulatory non-compliance.
•Assuming that a CRO is solely responsible for regulatory compliance without adequate sponsor oversight is a common pitfall.
•Not performing due diligence on a CRO's quality management system or therapeutic area expertise can result in compromised study data or delayed submissions.
•Lack of a comprehensive written agreement detailing all delegated tasks and responsibilities can create disputes and regulatory scrutiny.
•Overlooking the need for ongoing sponsor monitoring of CRO activities, even for seemingly minor tasks, can lead to critical errors being missed.

Frequently asked questions

The primary regulatory concern is ensuring that the sponsor maintains ultimate responsibility for the data integrity and regulatory compliance of the clinical study, even when delegating tasks to a CRO. This is emphasized in regulations such as 21 CFR Part 812 for devices.

Grouped by theme

Editor's picks

· Hand-selected related concepts

Clinical & Trials

Investigational Device Exemption(IDE)

FDA authorization to use an investigational device in a clinical study.

Standards

ISO 14155

Good clinical practice for clinical investigations of medical devices.

More in Industry Bodies

· Same category

Industry Bodies

AAMI(AAMI)

Standards body for medical instrumentation; co-publisher of ISO/IEC adoptions.

Industry Bodies

AdvaMed

U.S. trade association for the medical device and diagnostics industry.

Industry Bodies

AdvaMedDx

Diagnostics-focused division of AdvaMed.

Industry Bodies

Clinical and Laboratory Standards Institute(CLSI)

US-based consensus standards organization whose documents establish widely used analytical and clinical laboratory performance evaluation protocols for IVDs.

Cited by

Where this term appears across MedTech Terms.

Ecosystems (2)

Latest in MedTech

Sources

4 sources

Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

Tier 1Binding law and standards· 1Tier 4Trade press and expert commentary· 3

Link health: 4 verified· last checked 2026-06-20· added official documents checked 2026-11-01

ACRO·1AdvaMed·1MedTech Europe·1Electronic Code of Federal Regulations / FDA regulation·1

Inline markers like [1] jump to the matching reference above.

My progress

All terms0 / 513

Industry Bodies0 / 15

Saved on this device, and to your account when signed in. View studied terms

Full glossary

Browse all terms A to Z, each with a short definition.

On this term

Category: Industry Bodies
Acronym: CRO
Sources: 4
Updated: 5/5/2026

Compare with another term

Learn in 60 seconds

Service organization providing clinical trial management and supporting services to sponsors.

·Sponsors choose CROs based on therapeutic-area expertise, geographic site footprint, and budget - and increasingly on familiarity with EU MDR/IVDR clinical evidence expectations.
·MedTech-focused CROs differ from drug CROs in their handling of device-specific endpoints, IRB/EC strategy for IDE/CIP studies, and reimbursement-grade evidence design.

Remember this

Watch out: Failing to establish clear lines of responsibility and communication between the sponsor and the CRO can lead to regulatory non-compliance.

Related terms

You may also need

Auto-suggested from Industry Bodies and shared keywords.

All Industry Bodies terms